Ligand Pharmaceuticals (LGNDZ) Asset Utilization Ratio (2016 - 2025)
Ligand Pharmaceuticals (LGNDZ) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.18 as the latest value for Q4 2025.
- Quarterly Asset Utilization Ratio changed 0.16% to 0.18 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.18 through Dec 2025, changed 0.16% year-over-year, with the annual reading at 0.21 for FY2025, 10.83% up from the prior year.
- Asset Utilization Ratio hit 0.18 in Q4 2025 for Ligand Pharmaceuticals, down from 0.21 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.26 in Q1 2023 to a low of 0.14 in Q1 2024.
- Historically, Asset Utilization Ratio has averaged 0.19 across 5 years, with a median of 0.19 in 2021.
- Biggest five-year swings in Asset Utilization Ratio: soared 83.35% in 2021 and later crashed 46.27% in 2024.
- Year by year, Asset Utilization Ratio stood at 0.19 in 2021, then grew by 15.21% to 0.22 in 2022, then dropped by 22.05% to 0.17 in 2023, then increased by 4.45% to 0.18 in 2024, then rose by 0.16% to 0.18 in 2025.
- Business Quant data shows Asset Utilization Ratio for LGNDZ at 0.18 in Q4 2025, 0.21 in Q3 2025, and 0.2 in Q2 2025.